Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A 6-Month, Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Alendronate 280-mg Oral Buffered Solution Once Weekly in Patients With <
Brief Summary: To test the safety, effectiveness of MK0217 when taken once a week for six months in treating patients with Paget's bone disease.